Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products

Non-alcoholic fatty liver disease (NAFLD) affects up to 30% of the adult population and is now a major cause of liver disease-related premature illness and deaths in the world. Treatment is largely based on lifestyle modification, which is difficult to achieve in most patients. Progression of simple...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernando, Dinali H., Forbes, Josephine M., Angus, Peter W., Herath, Chandana B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834322/
https://www.ncbi.nlm.nih.gov/pubmed/31614491
http://dx.doi.org/10.3390/ijms20205037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834322/
https://www.ncbi.nlm.nih.gov/pubmed/31614491
http://dx.doi.org/10.3390/ijms20205037

Ejemplares similares